Rapidly Expanding Field of Gene Therapy $NTLA

Updated
I have know about this stock for over a year now, but I have never put the time into charting it. The time is near to buy in, and the patient investor will wait for the MACD to bottom out then buy.
Note
There has been some slight turbulence in the markets as of late, but to maintain trend lines is key. I did buy in @$21.40 and as long as the price continues to stay above my trend lines I will not sell a share.
biopharmaChart PatternsgenetherapyTechnical Indicators

Also on:

Disclaimer